Literature DB >> 11163155

DNA damage: Chk1 and Cdc25, more than meets the eye.

N C Walworth1.   

Abstract

Control of mitotic entry is a component of the checkpoint response that contributes to cell survival following DNA damage. In some eukaryotic cells, mitotic entry relies heavily on regulation of the state of tyrosine phosphorylation of the cyclin-dependent kinase Cdc2. Evidence that checkpoint regulation of cell-cycle progression operates through controlling the state of Cdc2 tyrosine phosphorylation exists. Whether other targets of the checkpoint pathway could play important roles in the response to DNA damage is a subject of ongoing investigations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163155     DOI: 10.1016/s0959-437x(00)00160-x

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  17 in total

1.  DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.

Authors:  Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 2.  14-3-3 proteins as signaling integration points for cell cycle control and apoptosis.

Authors:  Alexandra K Gardino; Michael B Yaffe
Journal:  Semin Cell Dev Biol       Date:  2011-09-14       Impact factor: 7.727

3.  Control of DNA replication and chromosome ploidy by geminin and cyclin A.

Authors:  Ivailo S Mihaylov; Takeshi Kondo; Lynn Jones; Sophia Ryzhikov; Junko Tanaka; Jianyu Zheng; Leigh Ann Higa; Naoto Minamino; Lynn Cooley; Hui Zhang
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  Alterations of Chk1 and Chk2 expression in colon cancer.

Authors:  Magdalena Stawinska; Adam Cygankiewicz; Radzislaw Trzcinski; Michal Mik; Adam Dziki; Wanda M Krajewska
Journal:  Int J Colorectal Dis       Date:  2008-08-05       Impact factor: 2.571

Review 5.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

6.  Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells.

Authors:  Patric Turowski; Celine Franckhauser; May C Morris; Philippe Vaglio; Anne Fernandez; Ned J C Lamb
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

7.  A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.

Authors:  Odile Mondesert; Matthieu Lemaire; Marie-Christine Brezak; Marie Odile Galera-Contour; Grégoire Prevost; Bernard Ducommun; Béatrix Bugler
Journal:  Curr Genet       Date:  2004-01-15       Impact factor: 3.886

8.  Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.

Authors:  S M Sureban; S Ramalingam; G Natarajan; R May; D Subramaniam; K S Bishnupuri; A R Morrison; B K Dieckgraefe; D J Brackett; R G Postier; C W Houchen; S Anant
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

9.  Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation.

Authors:  Shiaw-Yih Lin; Kaiyi Li; Grant S Stewart; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition.

Authors:  Ken Shimuta; Nobushige Nakajo; Katsuhiro Uto; Yoshimasa Hayano; Kenji Okazaki; Noriyuki Sagata
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.